|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| General and administrative expenses paid by related party | ||
| Interest income on investments held in the Trust Account | ||
| Change in fair value of forward sale securities | ||
| Changes in operating assets and liabilities: | ||
| Deferred offering costs | ||
| Prepaid expenses | ||
| Other assets | ||
| Accrued expenses | ||
| Net cash provided by (used in) operating activities | ||
| Cash flows from investing activities: | ||
| Cash deposited in the Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from Note payable – related party | ||
| Proceeds received from private placement | ||
| Offering costs paid | ||
| Deferred offering costs paid by related party | ||
| Proceeds from Notes payable – related party | ||
| Payment on Notes payable – related party | ||
| Payment on Payable to related party | ||
| Net cash provided by financing activities | ||
| Net change in Cash | ||
| Cash – end of the period | ||
| Deferred offering costs included in Accrued expenses | ||
| Supplemental disclosure of non-cash activities: | ||
| Deferred offering costs included in Accrued expenses |
Loading...
